PWM
NUVB icon

Palumbo Wealth Management’s Nuvation Bio NUVB Stock Holding History

Palumbo Wealth Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$585K Buy
102,955
+1,992
+2% +$9.74K 0.12% 127
2026
Q1 		$433K Sell
100,963
-62,793
-38% -$350K 0.11% 139
2025
Q4 		$1.47M Buy
163,756
+29,895
+22% +$185K 0.36% 54
2025
Q3 		$495K Buy
133,861
+20,195
+18% +$55K 0.16% 91
2025
Q2 		$222K Buy
113,666
+4,023
+4% +$8.38K 0.07% 175
2025
Q1 		$193K Buy
109,643
+44,283
+68% +$101K 0.06% 165
2024
Q4 		$174K Buy
65,360
+48,914
+297% +$126K 0.06% 158
2024
Q3 		$37.7K Sell
16,446
-11,904
-42% -$36.3K 0.01% 156
2024
Q2 		$82.8K Buy
28,350
+8,281
+41% +$25.3K 0.04% 141
2024
Q1 		$73.1K Buy
+20,069
New +$38.5K 0.03% 133

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Palumbo Wealth Management's NUVB Position: Q2 2026 in Review

Palumbo Wealth Management increased its Nuvation Bio (NUVB) stake by 2% in Q2 2026, buying an estimated $9.74K and bringing the position to 102,955 shares worth $585K. The position accounts for 0.12% of the portfolio, ranked #127.

Palumbo Wealth Management first reported a position in NUVB in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.47M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Palumbo Wealth Management held 102,955 shares of Nuvation Bio worth $585K as of Q2 2026.
  • Palumbo Wealth Management bought 1,992 Nuvation Bio shares in Q2 2026, an estimated $9.74K.
  • Nuvation Bio made up 0.12% of Palumbo Wealth Management's portfolio in Q2 2026, its #127 holding.
  • Palumbo Wealth Management first reported a position in Nuvation Bio in Q1 2024 and has held it in 10 quarters since.
  • Palumbo Wealth Management's Nuvation Bio position peaked at $1.47M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Palumbo Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.